作者 | 《财经》记者 辛颖 凌馨 编辑 | 王小 假功效还是真擦边？ 和科学家吵架结果未知，但热度下"科伦系"的市值管理大获成功 "秀肌肉"的75岁药企董事长和北大教授的口水战还在持续。 2025年6月8日，北京大学终身讲席教授、生物学家饶毅，已连续第四天在其个人公众号"饶议科学"发 文，质疑科伦药业（002422.SZ）董事长刘革新赤裸上身秀肌肉亲自宣传的产品麦角硫因胶囊，是"假 药"。 双方来往几个回合，到6月9日下午，科伦药业全资子公司科伦永年大健康再次发文，表示公司有关麦角 硫因相关临床研究正按既定计划推进。 麦角硫因，是一种天然水性含硫氨基酸，那么受到质疑的这款麦角硫因胶囊是假药吗？ "不属于保健品，也不是食品，因为产品比较新，目前正在推进其逐步在中国获批食品、保健品资 质。"这款麦角硫因胶囊产品的相关负责人对《财经》介绍。 6月9日晚间，科伦药业回复《财经》，已完成相关资料准备，即将向国家卫健委提交新食品原料的申 请。和其它同类麦角硫因胶囊一样，均通过跨境电商平台线上销售，是日本合法上市的产品。 受到质疑后，科伦药业股价在6月5日、6日连跌两天，但跌幅不大，约4.98%，此后有所回升。但与此 同 ...

Summary of Zhonggong International Conference Call Company Overview - Zhonggong International focuses on overseas markets with stable political environments and strong demand, particularly in regions like the Middle East, Central Asia, Southeast Asia, and Latin America [2][3] - The company has signed six overseas medical projects in collaboration with China Zhongyuan, leveraging design capabilities and international operational advantages to enhance its global market position [2][3] Key Points and Arguments Financial Performance - In Q1 2025, Zhonggong International achieved a net profit growth of over 12% year-on-year, with effective contracts increasing by 25% [3] - The company’s success is attributed to rolling development in key regions, such as the Nicaragua Hondaviet Airport project, which is the first RMB sovereign commercial loan project in Latin America [3] Strategic Expansion - Zhonggong International is diversifying into new sectors, particularly in oil and gas, with a focus on projects in Iraq and plans to expand into Oman and Algeria [2][4] - The company has also made significant progress in hospital construction, signing contracts for six hospitals across Asia, Africa, and Latin America [4][5] Collaboration with China Zhongyuan - The partnership with China Zhongyuan enhances the company's competitive edge in hospital design and construction, with a notable efficiency in project execution [5][7] - China Zhongyuan has designed a quarter of the top 100 hospitals in China, providing a strong foundation for international expansion [7] Equipment Manufacturing Sector - The equipment manufacturing segment, particularly the cableway products, has a domestic market share exceeding 70% and is expanding into Russian-speaking regions, Brazil, and Japan [8][9] - The company plans to strengthen its international presence, with a target of signing 15-16 cableway projects abroad, contributing nearly 20% to revenue [9] Market Development in Central Asia - The Central Asia region is a strategic focus due to its stable political relations with China and economic growth, with ongoing projects in waste-to-energy and chemical plants [12] - The company aims to deepen its engagement in this region, capitalizing on favorable conditions [12] Oil and Gas Sector Outlook - Despite oil price fluctuations, there is a continued need for oil and gas development in countries like Iraq, which heavily rely on oil for fiscal revenue [13][14] - The establishment of a dedicated engineering division for oil and gas projects indicates a commitment to expanding this sector [14] Shareholder and Market Value Management - Zhonggong International maintains a high dividend payout ratio, exceeding 40% of net profit attributable to shareholders, and has a three-year shareholder return plan [15] - The company actively engages with investors to improve market value management performance [15] Technological Innovation and National Reform - The company has become a high-tech enterprise, with ten subsidiaries recognized for their technological advancements and patent achievements [16][17] - Recent reforms focus on enhancing technological innovation, with measures in place to incentivize employees and promote the transformation of technological achievements into business growth [18][19] Additional Important Insights - The collaboration model with China Zhongyuan not only enhances competitiveness but also establishes a replicable development advantage in medical construction [6] - The company’s strategic focus on sustainable operations and international market expansion is expected to drive future growth [9][10]

2024 年三季报后，主粮价格下跌抑制农户购机需求，公司渠道库存偏 高，潍柴动力价格补贴导致毛利率下降 2-3%，多重因素导致公司基本 面恶化。 2025 年一季度大中拖销量同比下降 10%，四月单月销量同比下降 20% 左右，与农机流通协会指数匹配，反映行业景气度不佳。 2025 年三大主粮价格企稳反弹，公司内部及经销商库存回落至合理水 平，价格战趋于平稳，新任董事长推动出海战略，公司业绩有望筑底回 升。 第一拖拉机股份 H 股折价明显，仅相当于 A 股的 40%多，账上现金及 理财资产约 60 多亿，与 H 股市值接近，大量现金资产对 ROE 形成拖累。 公司计划回购并注销不超过 10%的 H 股，预计最快 2025 年 7 月开始， 需通过股东大会流程并完成外管局换汇，此举有望提升市场信心和公司 价值。 公司 H 股股息率超过 4.4%，现金流良好，具备提高分红的基础，但尚 未发布相关公告，建议关注后续公告。 预计 2025 年第二季度发货量仍为负，下半年有望同比转正，粮价触底 回升，渠道库存合理，行业或处于最差时期，即将迎来见底改善。 Q&A 港股依托第一拖拉机股份的投资机会如何？ 目前基本面仍然处于 ...

陕西烽火电子股份有限公司 市值管理办法 第一章 总 则 第一条 为进一步加强陕西烽火电子股份有限公司（以下简称"公司"）市 值管理工作，推动公司提升投资价值，增强投资者回报，维护公司、投资者及其 他利益相关者的合法权益，根据《中华人民共和国公司法》《中华人民共和国证 券法》 《国务院关于加强监管防范风险推动资本市场高质量发展的若干意见》 《上 市公司信息披露管理办法》《上市公司监管指引第 10 号——市值管理》《深圳证 券交易所股票上市规则》 《公司章程》及其他有关法律法规，结合公司实际情况， 特制定本办法。 第二条 本办法所称市值管理，是指公司以提高公司质量为基础，为提升公 司投资价值和股东回报能力而实施的战略管理行为。 第三条 公司要牢固树立回报股东意识，采取措施保护投资者尤其是中小投 资者利益，诚实守信、规范运作、专注主业、稳健经营，以新质生产力的培育和 运用，推动经营水平和发展质量提升，并在此基础上做好投资者关系管理，增强 信息披露质量和透明度，必要时积极采取措施提振投资者信心，推动公司投资价 值合理反映公司质量。 公司质量是公司投资价值的基础和市值管理的重要抓手。公司要立足提升公 司质量，依法依规运 ...

证券代码： 301362 证券简称：民爆光电 深圳民爆光电股份有限公司投资者关系活动记录表 | 投资者关系活动 | 分析师会议 □√特定对象调研 □ | | --- | --- | | 类别 □ | 媒体采访 业绩说明会 □ | | □ | 新闻发布会 □ 路演活动 | | □ | 现场参观 | | □ | 其他 （请文字说明其他活动内容） | | 参与单位名称及 | 现场调研 | | 人员姓名 | 深圳含金量私募、前海恒邦股权投资、华西证券、轻舟资本、诚 | | | 泽资产共 7 人 | | 时间 | 年 月 日 下午 2025 6 9 (周一) 15:00-16:30 | | 地点 | 深圳市宝安区福永街道（福园一路西侧）润恒工业厂区 2 栋 5 楼 | | | 会议室 | | 上市公司接待人 | 董事、副总经理兼董事会秘书 黄金元 | | 员姓名 | 证券事务代表 李娜 | | | Q:现在美国关税战，对公司发展有影响吗？ | | | A：尊敬的投资者您好，2024 年度，公司直接和间接出口至美国 | | | 市场的产品占总收入的比例约为 7.3%，美国加征关税对公司的 | | | 经营影响很小。未来， ...

Company Overview - Beijing Ruimait Medical Technology Co., Ltd. specializes in the manufacturing of medical devices and consumables in the respiratory health sector, with key products including various types of sleep breathing machines and monitoring devices [2] - The company holds a total of 633 domestic patents, including 107 invention patents, 390 utility model patents, and 136 design patents, as well as 202 international patents across multiple countries [2] Financial Performance - For the first quarter of 2025, the company reported a revenue of 265 million yuan, representing a year-on-year increase of 38.11%, and a net profit of 71.93 million yuan, up 44.11% year-on-year, with a gross profit margin of 49.57% [2] Market Position - As of June 9, the company's stock closed at 84.6 yuan, down 1.12%, with a rolling price-to-earnings (PE) ratio of 42.73 times, and a total market capitalization of 7.58 billion yuan [1] - In comparison to the medical device industry, which has an average PE ratio of 50.64 times and a median of 37.05 times, Ruimait ranks 85th in terms of PE ratio [1][3] Shareholding Structure - As of the first quarter of 2025, a total of 14 institutions held shares in Ruimait, including 6 funds, 5 other institutions, 2 brokerages, and 1 social security fund, with a total holding of 26.92 million shares valued at 2.172 billion yuan [1]

Group 1 - The core viewpoint of the news is that Chao Yan Co., Ltd. has a high rolling price-to-earnings (PE) ratio of 70.66, significantly above the industry average of 50.64, indicating a premium valuation in the medical device sector [1][2] - As of June 9, the company's stock closed at 26.11 yuan, with a market capitalization of 11.184 billion yuan, reflecting a 1.28% increase [1] - The company has experienced a net outflow of main funds amounting to 245.27 million yuan on June 9, with a total outflow of 2,328.49 million yuan over the past five days [1] Group 2 - Chao Yan Co., Ltd. specializes in the research, production, and sales of medical imaging equipment and industrial non-destructive testing equipment, with key products including industrial ultrasound, medical ultrasound, and X-ray equipment [1] - The company has established a strong market presence and customer base, with its industrial ultrasound non-destructive testing products recognized as a Guangdong Province brand product [1] - In 2022, the company received a second-class award for national defense technology invention from the Ministry of Industry and Information Technology for its project on "New Technology for High-Precision Non-Destructive Testing of Complex Large Components and Its Major Applications" [1] Group 3 - The latest financial results for the first quarter of 2025 show that the company achieved an operating income of 98.4324 million yuan, representing a year-on-year increase of 28.69%, and a net profit of 39.3220 million yuan, up 47.70% year-on-year, with a gross profit margin of 73.83% [1]

证券研究报告：金融工程报告 发布时间：2025-06-09 研究所 研究所 分析师:肖承志 SAC 登记编号:S1340524090001 Email:xiaochengzhi@cnpsec.com 研究助理:金晓杰 SAC 登记编号:S1340124100010 E研ma究il所:jinxiaojie@cnpsec.com 近期研究报告 近期研究报告 《结合基本面和量价特征的 GRU 模型》 - 2025.06.05 《DeepSeek-R1 完成小版本更新，阿里 开源自主搜索 AI 智能体——AI 动态汇 总 20250602》 - 2025.06.03 《Claude 4 系列发布，谷歌上线编程智 能体 Jules——AI 动态汇总 20250526》 - 2025.05.27 《谷歌发布智能体白皮书，Manus 全面 开放注册——AI 动态汇总 20250519》 - 2025.05.20 《证监会修改《重组办法》，深化并购重 组改革——微盘股指数周报 20250518》 - 2025.05.19 《通义千问发布Qwen-3模型，DeepSeek 发布数理证明大模型——AI 动态汇总 20250505 ...

【今日新股】 今日无新股申购，无新股上市。 •周五（2025年6月6日），港股三大指数集体走软，截止收盘，恒生指数跌0.48%或114.43点，报 23792.54点，全日成交额为2356.22亿港元；恒生国企指数跌0.63%，报8629.75点；恒生科技指数跌 0.63%，报5286.52点。全周来看，恒指累涨2.16%，国指累涨2.34%，恒科指累涨2.25%。 •周五（当地时间2025年6月6日），美股三大指数涨跌不一，截至收盘，道琼斯指数涨1.05%，报 42,762.87点；标普500指数涨1.03%，报6,000.36点；纳斯达克指数涨1.20%，报19,529.95点。 【隔夜行情】 •周五（2025年6月6日），A股三大指数涨跌不一，截至收盘，微涨0.04%，报3385.36点，实现"四连 涨"，周累计涨幅超1%。深证成指：下跌0.19%，报10183.7点。创业板指：下跌0.45%，报2039.44点； 北证50跌0.53%。成交缩量：两市成交额11,518亿–11,772亿元，较前一日减少约1,383亿–1,398亿元 【重要新闻】 【国家外汇管理局：截至5月末 我国外汇储备规模为3285 ...

南财早新闻，早听早知道。 今日关注 5、广东省广州市2025年首批配售型保障性住房选房顺序号摇号仪式6月7日举行，经公开摇号，萝岗和 苑项目1714户申请家庭与嘉翠苑项目715户申请家庭的选房顺序号已确定。 投资要闻 近日，多家知名外资机构上调中国经济增速预期和股指目标点位，表达对中国经济和中国资产的看好。 摩根士丹利宣布，上调中国股指的目标点位。高盛也发布研报称，鉴于人民币对美元汇率走强，维持对 中国股票的增持立场。机构认为，中国经济增长预期向好、企业盈利前景改善、中国资产估值相对较 低，增强了中国市场、中国资产对全球投资者的中长期吸引力。 宏观经济 1、6月8日是全国高考的第二天，随着下午外语科目考试结束，语文、数学、外语三门高考统考科目考 试全部结束。已有部分省份公布了高考成绩查询时间，湖南、湖北、吉林、江西等地，预计在6月25日 左右公布高考成绩。 2、国家统计局数据显示，1—4月规模以上工业中小企业增加值同比增长8.2%，营业收入达25.8万亿 元，其中装备制造业、原材料制造业因技术升级带动需求增长显著，31个制造业大类中28个实现增长。 3、据统计，全国至少已有27个省份在地方性法规中明确延长婚假 ...